Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 37.17M P/E - EPS this Y 19.30% Ern Qtrly Grth -
Income -27.79M Forward P/E -1.18 EPS next Y - 50D Avg Chg -22.00%
Sales 930k PEG - EPS past 5Y - 200D Avg Chg -32.00%
Dividend N/A Price/Book 0.88 EPS next 5Y - 52W High Chg -73.00%
Recommedations 2.00 Quick Ratio 8.00 Shares Outstanding 41.19M 52W Low Chg 16.00%
Insider Own 6.11% ROA -26.10% Shares Float 39.71M Beta 0.87
Inst Own 6.84% ROE -50.61% Shares Shorted/Prior 725.86K/827.99K Price 0.79
Gross Margin 17.53% Profit Margin - Avg. Volume 110,700 Target Price 12.50
Oper. Margin -3,328.28% Earnings Date - Volume 762 Change 1.27%
Evogene Ltd. News
09/21/22 Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles
09/14/22 Lavie Bio Announces Appointment of Guri Oron as CEO
09/13/22 Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida
09/07/22 Evogene to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08/31/22 Evogene (EVGN) Reports Q2 Loss, Tops Revenue Estimates
08/31/22 Evogene Reports Second Quarter 2022 Financial Results
08/25/22 Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
08/17/22 ADDING MULTIMEDIA ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
08/02/22 Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2022
07/28/22 Biomica Appoints Professor Gal Markel to Company's Scientific Advisory Board
06:00 AM Biomica Announces First Patient Dosed in its Phase I Study of its Microbiome-Based Immuno-Oncology Drug
07/11/22 Biomica Announces Successful Enrollment of First Patient in its Phase I Study of Microbiome-Based Immuno-Oncology Drug
07/05/22 Biomica to Present at the Microbiome Connect Europe 2022
06/15/22 Biomica to Present at the 7th Microbiome Movement Drug Development Summit
07:25 AM Evogene (EVGN) Reports Q1 Loss, Lags Revenue Estimates
06:00 AM Evogene Reports First Quarter 2022 Financial Results
05/23/22 Biomica to Present at the ASCO 2022 Annual Meeting
05/16/22 Biomica to Present at the 2022 Digestive Disease Week (DDW) Conference
05/11/22 Lavie Bio Announces Successful Product Launch of its Bio-Inoculant resultβ„’ for the 2022 Spring Wheat Growing Season

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

EVGN Chatroom

User Image Teo2021 Posted - 2 days ago

$EVGN Bears have a plan.

User Image SuperMoron Posted - 2 days ago

$EVGN just great

User Image Stonkmoon Posted - 4 days ago

$EVGN 2022-09-21 07:04 ET Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://stonkmoon.com/news/EVGN/9cb69cd158fe08e3a6a5464de98a87a5

User Image tickeron Posted - 4 days ago

The market looks weird..Do not be too greedy today! $EVGN in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://srnk.us/go/4008696

User Image SuperMoron Posted - 4 days ago

$EVGN better off with no news on this stock

User Image pendalfuji Posted - 5 days ago

$EVGN Well, what are the forecasts and prospects, just be patient and buy

User Image ChartMill Posted - 5 days ago

$EVGN: Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://www.chartmill.com/news/EVGN/prnews-2022-9-21-canonic-launches-its-second-generation-medical-cannabis-products-with-high-thc-and-unique-terpene-profiles?utm_source=stocktwits&utm_medium=pressRelease&utm_content=EVGN&utm_campaign=social_tracking

User Image STCKPRO Posted - 5 days ago

$EVGN NEW ARTICLE : Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://www.stck.pro/news/EVGN/34594054

User Image fla Posted - 5 days ago

$EVGN [15s. delayed]: Issued Press Release on September 21, 07:04:00: Canonic Launches its Second-Generation Medical Cannabis Products wit https://s.flashalert.me/EauML

User Image Stonkmoon Posted - 5 days ago

$EVGN 2022-09-21 07:04 ET Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://stonkmoon.com/news/EVGN/9cb69cd158fe08e3a6a5464de98a87a5

User Image Quantisnow Posted - 5 days ago

$EVGN πŸ“° Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://quantisnow.com/i/3435449?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 5 days ago

$EVGN Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://www.stocktitan.net/news/EVGN/canonic-launches-its-second-generation-medical-cannabis-products-fcuigy38bggo.html

User Image Newsfilter Posted - 5 days ago

$EVGN Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles https://newsfilter.io/a/9cb69cd158fe08e3a6a5464de98a87a5

User Image Quantisnow Posted - 5 days ago

$EVGN πŸ“œ SEC Form 6-K filed by Evogene Ltd https://quantisnow.com/i/3435436?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 5 days ago

$EVGN [15s. delayed] filed form 6-K on September 21, 07:00:27 https://s.flashalert.me/LBjiK

User Image Newsfilter Posted - 5 days ago

$EVGN Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC https://newsfilter.io/a/4c2e989e69ae0ade1706183a93c7450a

User Image pendalfuji Posted - 5 days ago

$EVGN they are going down, it's panicky scary, yes, it already happened, everything will be back soon

User Image akts Posted - 5 days ago

$EVGN Another day, another 10% drop. Now $.87. This is going deeper down. Looking at a reverse split coming up. From $.50, figure 1:10. Not a pretty overall picture. And lets not forget.....they will need to do a RAISE. Ouch!!!!! Revenues and future profits will be dramatically outpaced by cash burn.

User Image pendalfuji Posted - 1 week ago

$EVGN Yuan Keenan, CEO of GroVida commented: β€œAs a company with several years of experience in the EU cannabis market, we have been impressed with the quality of the cannabis strains developed by Canon and especially with their performance in our growing conditions in Portugal. We see significant sales potential for these varieties in our home market in Europe and we are pleased with this new licensing agreement. We look forward to starting and increasing sales of products based on these strains

User Image SuperMoron Posted - 1 week ago

$EVGN

User Image Newsfilter Posted - 1 week ago

$EVGN Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC https://newsfilter.io/a/fdc8054481418769fde7ff9755adfb89

User Image Quantisnow Posted - 1 week ago

$EVGN πŸ“œ SEC Form 6-K filed by Evogene Ltd https://quantisnow.com/i/3418105?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 1 week ago

$EVGN [15s. delayed] filed form 6-K on September 15, 16:00:12 https://s.flashalert.me/nIgV3L

User Image Quantisnow Posted - 1 week ago

$EVGN πŸ“œ SEC Form 6-K filed by Evogene Ltd https://quantisnow.com/i/3414484?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 1 week ago

$EVGN [15s. delayed] filed form 6-K on September 15, 07:02:31 https://s.flashalert.me/ulddW

User Image stockilluminati Posted - 1 week ago

$EVGN https://www.stockilluminati.com/evgn/filings.php - Evogene Ltd. - Ordinary Shares files form 6-K today, check out the details.

User Image Newsfilter Posted - 1 week ago

$EVGN Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC https://newsfilter.io/a/72fcbeaf8094b2c4b19fc30aa9f096e9

User Image Stonkmoon Posted - 1 week ago

$EVGN 2022-09-14 07:00 ET Lavie Bio Announces Appointment of Guri Oron as CEO https://stonkmoon.com/news/EVGN/c37436037e4de4e120892689996fb810

User Image Stonkmoon Posted - 1 week ago

$EVGN 2022-09-14 07:00 ET Lavie Bio Announces Appointment of Guri Oron as CEO https://stonkmoon.com/news/EVGN/c37436037e4de4e120892689996fb810

User Image Quantisnow Posted - 1 week ago

$EVGN πŸ“œ SEC Form 6-K filed by Evogene Ltd https://quantisnow.com/i/3409005?utm_source=stocktwits 45 seconds delayed.

Analyst Ratings
Roth Capital Buy Oct 8, 21
Aegis Capital Buy Jul 29, 21
Cantor Fitzgerald Overweight Dec 1, 20
Credit Suisse Outperform Nov 12, 14
Deutsche Bank Buy Dec 17, 13
Credit Suisse Outperform Dec 16, 13